| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +100 | 0.2% | $24.82 | +$2.48K |
| Sells | 1 | -50.1K | 99.8% | $41.76 | -$2.09M |
| Net | 0 | -50K | -99.6% | -$2.09M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin Robert Lind | CEO, Director | $1.14M | Nov 13, 2024 | ||
| Randall Kaye | Cmo | $291K | -$2.09M | -87.8% | Nov 19, 2024 |
| Brandi Roberts | Cfo | $63.4K | Oct 25, 2024 | ||
| Paul J. Sekhri | Director | May 23, 2024 | |||
| Casey Lynch | Director | May 23, 2024 | |||
| Jane Tiller | Director | May 25, 2023 | |||
| Philip Perera | Cmo | Feb 9, 2022 | |||
| Arena Pharmaceuticals Inc | Former 10% Owner | Jan 25, 2024 | |||
| Corinne Le Goff | Director | May 23, 2024 | |||
| Vincent Aurentz | Director | May 23, 2024 | |||
| Phillip M. Schneider | Director | May 23, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|